Gossec, L., Flipo, R. M., Schaeverbeke, T., Albert, C., Baillet, A., Boissier, M. C., Confavreux, C., Cormier, G., Dernis, E., Gervais Solau, E., Godot, S., Gottenberg, J. E., Goupille, P., Lassoued, S., Lequerre, T., Lioté, F., Marcelli, C., Maugars, Y., Nguyen, M., Perdriger, A., Pers, Y. M., Pertuiset, E., Poiroux, L., Rosenberg, C., Roux, C., Ruyssen-Witrand, A., Soubrier, M., Vergne-Salle, P., Zarnitsky, C., Fakra, E., Marotte, H., & Lévy-Weil, F. E. (n.d.). fRI0095 SARILUMAB IMPROVED PATIENT-PERCEIVED IMPACT OF RHEUMATOID ARTHRITIS WHATEVER THE BASELINE DISEASE ACTIVITY: FIRST RESULTS FROM AN INTERVENTIONAL NON CONTROLLED STUDY: SARIPRO, IN MODERATE AND SEVERE RHEUMATOID ARTHRITIS PATIENTS. Annals of the rheumatic diseases, 79, 626. http://access.bl.uk/ark:/81055/vdc_100144710044.0x00003d